How weight loss drugs pose challenges for plastic surgeons
The popularity of GLP-1 drugs has created a new generation of body contouring patients and a new set of challenges for plastic surgeons.
Jul 16, 2026
0
6
The popularity of GLP-1 drugs has created a new generation of body contouring patients and a new set of challenges for plastic surgeons.
Jul 16, 2026
0
6
Why do some people lose substantial weight with GLP-1-based medications while others see more modest results? A Mayo Clinic study offers a potential answer by identifying a distinct biological subtype of obesity that responds ...
Jul 16, 2026
0
5
The common rationale for drinking water at meals is that it physically stretches the stomach, triggering fullness so you don't eat too much. But a new Cornell study found no support for that idea in practice. The paper is ...
Jul 16, 2026
0
37
As use of GLP-1s surged across the U.S., average total payments per user also climbed sharply, according to a new Northwestern University study that analyzed national trends in GLP-1 use and spending between 2017 and 2022. ...
Jul 16, 2026
0
5
A meta-analysis of 10 randomized controlled trials involving more than 23,000 participants, presented at the International Congress on Obesity (ICO 2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico ...
Jul 16, 2026
0
4
New research presented at the International Congress on Obesity (ICO2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico, (15โ17 July) asks what is driving the obesity pandemic.
Jul 16, 2026
0
14
Drugs commonly used for weight loss, known as GLP-1 receptor agonists, have been found to reduce the key symptoms of binge eating disorder in a new review of evidence led by University College London (UCL) researchers.
Jul 15, 2026
0
6
A new systematic review and meta-analysis presented at the International Congress on Obesity (ICO2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico, July 15โ17, is the first study to show that behavioral ...
Jul 15, 2026
0
4
Public interest in obesity medication has risen 25-fold since the launch of GLP-1 receptor agonist drugs, new research presented at the International Congress on Obesity (ICO2026) in Mexico City, Mexico, hosted by the World ...
Jul 15, 2026
0
20
New research being presented at the International Congress on Obesity (ICO2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico (July 15โ17), reveals how Coca-Cola's sponsorship of the 2025 FIFA Club ...
Jul 15, 2026
0
6